Synonyms: asparaginase | Elspar® | Enrylaze® | L-asparaginase | L-asparagine amidohydrolase
crisantaspase is an approved drug (FDA (no history prior to 2011), EMA (2023))
Compound class:
Peptide
Comment: Crisantaspase is a chemotherapy agent. The asparaginase enzyme can be isolated from Erwinia chrysanthemi or Escherichia coli. The two forms have different immunogenicity profiles. The amino acid sequence shown here is for the Erwina isoform, crisantaspase.
|
Bioactivity Comments |
The substrate for this enzyme is L-asparagine, which it converts to aspartic acid and ammonia. We have not tagged a primary target for this enzyme drug. |